Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
11:40am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) * Acceleron Pharma Inc (NASDAQ: XLRN)(reacted to its f
Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q1 2020 Results - Earnings Call Transcript
03:20am, Wednesday, 13'th May 2020
Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2020 Earnings Conference Call May 12, 2020 16:30 ET Company Participants Bryan Giraudo - Chief Financial Officer Sheila Gujr
LOS ANGELES, CA / ACCESSWIRE / May 12, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Gossamer Bio, Inc. ("Gossamer"
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Aerpio Pharmaceuticals, Inc. (“Aerpio”) (ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
08:01pm, Tuesday, 12'th May 2020
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflamm
SHAREHOLDER ALERT: GOSS SERV HALL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
02:30pm, Tuesday, 12'th May 2020
NEW YORK, NY / ACCESSWIRE / May 12, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a lo
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
01:00pm, Tuesday, 12'th May 2020
NEW YORK, NY / ACCESSWIRE / May 12, 2020 / Pomerantz LLP is investigating claims on behalf of investors Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ:GOSS). Such investors ...
SHAREHOLDER ALERT: GOSS ZM IQ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
01:20am, Tuesday, 12'th May 2020
NEW YORK, NY / ACCESSWIRE / May 11, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a lo
LOS ANGELES, CA / ACCESSWIRE / May 11, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Gossamer Bio, Inc. ("Gossamer"
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of XP, GOSS and BIDU
04:30pm, Sunday, 10'th May 2020
NEW YORK, NY / ACCESSWIRE / May 10, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participa
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. – GOSS
03:15pm, Sunday, 10'th May 2020
Pomerantz LLP is investigating claims on behalf of investors Gossamer Bio, Inc. (“Gossamer” or the “Company”) (GOSS). Such investors are advised to contact Robert S. Willoughby at rswilloughb
CLASS ACTION UPDATE for GOSS, SERV and DNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
03:00pm, Sunday, 10'th May 2020
NEW YORK, NY / ACCESSWIRE / May 10, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
